Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Cancer Research

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-08-0066PMID 18723828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs)

  2007cited by this paper
• DNA damage signalling guards against activated oncogenes and tumour progression

  2007cited by this paper
• Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells

  2007cited by this paper
• Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.

  2007cited by this paper
• Regulation and biological activities of the autotaxin-LPA axis.

  2007cited by this paper
• Loss of p53 promotes RhoA–ROCK-dependent cell migration and invasion in 3D matrices

  2007cited by this paper
• Control of cell migration: a tumour suppressor function for p53?

  2006cited by this paper
• Differential expression of lysophosphatidic acid receptor‐2 in intestinal and diffuse type gastric cancer

  2006cited by this paper
• Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

  2006cited by this paper
• Re-evaluating cell-cycle regulation by E2Fs.

  2006cited by this paper
• Transcriptional regulation by p53: one protein, many possibilities

  2006cited by this paper
• Oncogene-induced senescence as an initial barrier in lymphoma development

  2005cited by this paper
• Tumour biology: Senescence in premalignant tumours

  2005cited by this paper
• Rho GTPase expression in tumourigenesis: Evidence for a significant link

  2005cited by this paper
• P53 and prognosis: new insights and further complexity.

  2005cited by this paper
• Human cell senescence as a DNA damage response.

  2005cited by this paper
• Rho GTPases: biochemistry and biology.

  2005cited by this paper
• BRAFE600-associated senescence-like cell cycle arrest of human naevi

  2005cited by this paper
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

  2005cited by this paper
• G1 cell-cycle control and cancer

  2004cited by this paper
• When cells get stressed: an integrative view of cellular senescence.

  2004cited by this paper
• Intrinsic tumour suppression

  2004cited by this paper
• Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion

  2004cited by this paper
• The ins and outs of lysophosphatidic acid signaling

  2004cited by this paper
• Metabolic channelling of carbamoyl phosphate in the hyperthermophilic archaeon Pyrococcus furiosus: dynamic enzyme-enzyme interactions involved in the formation of the channelling complex.

  2004cited by this paper
• Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)

  2004cited by this paper
• Involvement of Rho Family GTPases in p19Arf- and p53-Mediated Proliferation of Primary Mouse Embryonic Fibroblasts

  2004cited by this paper
• Spider and Bacterial Sphingomyelinases D Target Cellular Lysophosphatidic Acid Receptors by Hydrolyzing Lysophosphatidylcholine*

  2004cited by this paper
• The emerging role of lysophosphatidic acid in cancer

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

  2003cited by this paper
• Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53* 210

  2003cited by this paper
• The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 ARF via a Variant T-site in the Initiator*

  2002cited by this paper
• International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

  2002cited by this paper
• The RB and p53 pathways in cancer.

  2002influential reference
• RhoGEF Specificity Mutants Implicate RhoA as a Target for Dbs Transforming Activity

  2002cited by this paper
• TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 ARF and Inhibits Senescence*

  2002cited by this paper
• Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells

  2002cited by this paper
• Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.

  2002cited by this paper
• Lysophospholipid receptor nomenclature.

  2002cited by this paper
• E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.

  2002influential reference
• Regulation of Cdc42‐mediated morphological effects: a novel function for p53

  2002cited by this paper
• Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: Over‐expression of the high‐affinity receptor edg4 in differentiated thyroid cancer

  2001cited by this paper
• Post-translational modifications and activation of p53 by genotoxic stresses.

  2001cited by this paper
• Regulation and function of the p53 tumor suppressor protein.

  2001cited by this paper
• Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

  2000cited by this paper
• Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers

  2000cited by this paper
• NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

  2000cited by this paper
• Cellular senescence: mitotic clock or culture shock?

  2000cited by this paper
• Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

  2000cited by this paper
• Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Genes involved in senescence and immortalization.

  2000cited by this paper
• Lysophosphatidic acid receptors.

  2000cited by this paper
• Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

  2000cited by this paper
• Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

  2000cited by this paper
• Lysophosphatidic acid: receptors, signaling and survival

  2000cited by this paper
• Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells

  2000cited by this paper
• Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Tumor surveillance via the ARF-p53 pathway.

  1998cited by this paper
• Malignant effusions contain lysophosphatidic acid (LPA)-like activity.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• The Dbl family of oncogenes.

  1996cited by this paper
• Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia.

  1995cited by this paper
• Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

  1995influential reference
• Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.

  1995cited by this paper
• E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis

  1995cited by this paper
• Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger (*)

  1995cited by this paper
• Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.

  1995cited by this paper
• Lysophospholipids activate ovarian and breast cancer cells.

  1995cited by this paper
• A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways.

  1994cited by this paper
• LPA: a novel lipid mediator with diverse biological actions.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.

  1993cited by this paper
• The effect of active serum albumin on PC12 cells: I. Neurite retraction and activation of the phosphoinositide second messenger system.

  1992cited by this paper

• Klotho and aging phenotypes

  2021cites this paper
• Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

  2020cites this paper
• Lysophosphatidic acid receptor LPA3 prevents oxidative stress and cellular senescence in Hutchinson–Gilford progeria syndrome

  2019cites this paper
• G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence

  2019cites this paper
• The Unique Molecular and Cellular Microenvironment of Ovarian Cancer

  2017cites this paper
• Regulation of lysophosphatidate-induced mechanisms of chemo-resistance

  2015cites this paper
• Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition

  2015cites this paper
• Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.

  2015cites this paper
• Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer.

  2015cites this paper
• Blood Pressure Regulation and Pathology

  2014cites this paper
• Rho GTPases modulate malignant transformation of tumor cells

  2014cites this paper
• Role of Plasminogen Activator Inhibitor-1 in Senescence and Aging

  2014cites this paper
• Inactivate the two-faced HDAC-brake : Cell cycle regulation and tumor suppression by histone deacetylases HDAC 1 and HDAC 2

  2013cites this paper
• Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.

  2013cites this paper
• Understanding the Functions of Lysophosphatidic Acid Receptors in Cancer

  2013cites this paper
• through regulation of c-Myc collaborating genes and p53 function Dosage-dependent tumor suppression by histone deacetylases 1 and 2

  2013cites this paper
• Exocrine Pancreatic Carcinogenesis and Autotaxin Expression

  2012cites this paper
• Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?

  2012cites this paper
• TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis

  2011cites this paper
• Angiotensin II and the vascular phenotype in hypertension

  2011cites this paper
• How to become immortal: let MEFs count the ways

  2010cites this paper
• Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression

  2010cites this paper
• New method for determination of average scFv fragment number displayed on the M13 phage surface

  2010cites this paper
• Hallmarks for senescence in carcinogenesis: novel signaling players

  2009cites this paper